Podcast 2: C3 glomerulopathy treatment now and in the future – how can we address unmet needs?

In this podcast episode, Dr Nester and Dr Andrew Bomback discuss current strategies and key unmet needs in the treatment of C3G. Dr Bomback explores investigational approaches to target the underlying cause of disease pathophysiology, including complement inhibition, and the importance of patient access to clinical trials. Both experts then close the podcast with a discussion on wish list items that would help to address these needs and other treatment challenges in the future.